Trial intelligence / Profile preview

Serotonin and the Upper Airway in OSA

NCT00100464Phase 4Completed

Sponsor
United States Department of Veterans Affairs
Start
Nov 2000
Primary completion
Dec 2003
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of paroxetine, 5-hydroxytryptophan in obstructive sleep apnea (OSA), sponsored by United States Department of Veterans Affairs. Started Nov 2000; status: completed.

02

Drugs

paroxetine5-hydroxytryptophan
03

Conditions

obstructive sleep apnea (OSA)

Beyond the preview

Go deeper on NCT00100464.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00100464.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call